Dermatology · Thomasville, GA
NPI
1447219548
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
119 W Hill St
Thomasville, GA, 31792
Phone (229) 225-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$290K
7,911 services
Medicare patients, 2024
1,037
Average age 77
Drug cost, 2024
$1.5M
3,125 prescriptions
Company payments, 2025
$878
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel F Mitchell was code 17003 (destruction skin lesion), 2,883 times for 457 patients. In total Daniel F Mitchell billed 7,911 services in 93 codes, and Medicare paid $290K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,883 | 457 | $4.42 | $13K |
| 99213 Office E&M - Established | Office | 1,573 | 896 | $58.89 | $93K |
| 17000 Destruction Skin Lesion | Office | 900 | 582 | $33.57 | $30K |
| 17110 Destruction Skin Lesion | Office | 414 | 343 | $58.21 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 237 | 197 | $10.68 | $2,532 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 172 | 20 | $0.72 | $124 |
| 99212 Office E&M - Established | Office | 166 | 151 | $37.21 | $6,177 |
| 99214 Office E&M - Established | Office | 164 | 135 | $75.54 | $12K |
| 11302 Removal or Shaving of Skin Growth | Office | 108 | 100 | $77.46 | $8,365 |
| 11301 Removal or Shaving of Skin Growth | Office | 104 | 98 | $66.95 | $6,963 |
| 11104 Skin Biopsy | Office | 101 | 95 | $70.58 | $7,129 |
| 17004 Destruction Skin Lesion | Office | 93 | 67 | $94.13 | $8,754 |
| 11311 Removal or Shaving of Skin Growth | Office | 77 | 73 | $73.54 | $5,662 |
| 11312 Removal or Shaving of Skin Growth | Office | 67 | 60 | $93.45 | $6,261 |
| 11307 Removal or Shaving of Skin Growth | Office | 51 | 49 | $78.98 | $4,028 |
By year: 2022 $345K for 8,207 services; 2023 $312K for 8,567 services; 2024 $290K for 7,911 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 24 | $8.65 | $225 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel F Mitchell prescribed most often to Medicare patients was Triamcinolone Acetonide, with 392 prescriptions and refills. In total Daniel F Mitchell wrote 3,125 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 392 | 423 | 232 | $5,818 |
| Doxepin Hcl Generic | 239 | 263 | 55 | $3,604 |
| Finasteride Generic | 189 | 256 | 36 | $1,379 |
| Clobetasol Propionate Generic | 178 | 187 | 90 | $6,476 |
| Ketoconazole Generic | 172 | 187 | 83 | $2,747 |
| Hydrocortisone Generic | 170 | 209 | 105 | $2,186 |
| Mupirocin Generic | 159 | 163 | 106 | $1,196 |
| Hydroxyzine Hcl Generic | 115 | 143 | 31 | $940 |
| Doxycycline Monohydrate Generic | 109 | 122 | 57 | $1,750 |
| Doxycycline Hyclate Generic | 86 | 105 | 42 | $1,149 |
| Minoxidil Generic | 81 | 138 | 15 | $1,818 |
| Fluconazole Generic | 78 | 153 | 30 | $1,457 |
| Terbinafine Hcl Generic | 58 | 96 | 27 | $691 |
| Imiquimod Generic | 56 | 65 | 41 | $1,652 |
| Dutasteride Generic | 44 | 54 | Under 11 | $416 |
Brand drugs: 161 claims; generic drugs: 2,964 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel F Mitchell $878 ($878 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $249.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $249 |
| Pfizer Inc. PFE | 15 | $143 |
| Lilly USA, LLC LLY | 3 | $106 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $94.54 |
| LEO Pharma Inc. | 3 | $73.71 |
| Janssen Biotech, Inc. JNJ | 1 | $65.99 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $56.77 |
| UCB, Inc. UCB.BR | 1 | $20.38 |
| Verrica Pharmaceuticals Inc. VRCA | 1 | $18.35 |
| Seqirus USA Inc CSL.AX | 1 | $18.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.